Latest News

Elon Musk has grand ambitions across two of his largest businesses, SpaceX and Tesla.

Dividend investors seek out companies that can raise their payouts consistently each year.

Vertex is betting on nephrology and rare endocrinology to build a fifth and fourth commercial pillar beyond cystic fibrosis.

One overlooked point could change how investors see this quantum computing company. Explore what its financial results reveal about the growth opportunity and the risks ahead.

Expanding beyond a handful of customers to 12+ accounts reduces execution risk as the company scales production.

Oilfield services provider Expro (NYSE:XPRO) missed Wall Street’s revenue expectations in Q3 2026, but revenue rose 6.9% year on year to $439.9 million. On t...

Hiscox (LON:HSX) reported a 9.5% increase in insurance contract written premiums for the first nine months of 2026, surpassing $4.4 billion, as momentum accelerated across its retail operations and growth initiatives offset active underwriting discipline in big-ticket insurance and reinsurance. Chi

NuScale Power needs to sign its first reactor contract before it can take its next big step as a business.

Industrial products and automation company Regal Rexnord (NYSE:RRX) reported Q3 2026 results beating Wall Street’s revenue expectations, with revenue up 6.1%...

Investment banking firm PJT Partners (NYSE:PJT) fell short of the market’s revenue expectations in Q3 2026, with revenue falling 13.9% year on year to $385.1...

Security technology and services company ADT (NYSE:ADT) reported revenue ahead of Wall Street’s expectations in Q3 2026, with revenue up 3.9% year on year to...

NARCAN's market lead persists despite pricing pressure, signaling the brand's resilience as the company executes its turnaround.

Material handling equipment manufacturer Columbus McKinnon (NASDAQ:CMCO) announced better-than-expected revenue in calendar Q3 2026 (fiscal Q2 2027), with re...

Amazon's management team is forecasting at least 40% growth in its most lucrative segment for 2027 and 2028.

Rising Treasury yields were bad news for many companies.

A shift to higher-margin kit distribution and a successful red blood cell trial position Cerus for path to GAAP profitability.

A $100 contribution each month for 20 years could help you build a lot of wealth.

Cloud observability platform Dynatrace (NYSE:DT) reported calendar Q3 2026 (fiscal Q2 2027) results topping the market’s revenue expectations, with revenue u...

Operating leverage is converting revenue growth into profit faster than the top line, a structural advantage that compounds as the network scales.

Enterprise data capture company Zebra Technologies (NASDAQ:ZBRA) reported Q3 2026 results beating Wall Street’s revenue expectations, with revenue up 22.3% y...

Food processing and aviation equipment manufacturer JBT Marel (NYSE:JBTM) fell short of the market’s revenue expectations in Q3 2026, with revenue flat year ...

Companies are recognizing revenue now. But the costs are only likely to start showing up in the years ahead.

Consumer packaging solutions provider Graphic Packaging Holding (NYSE:GPK) announced better-than-expected revenue in Q3 2026, but revenue was flat year on ye...

Alphabet's planned crypto custody platform is catering to institutions that are increasingly concerned about their cybersecurity.

Dental and medical products company Henry Schein (NASDAQ:HSIC) met Wall Street’s revenue expectations in Q3 2026, with revenue up 4% year on year to $3.47 bi...